✦ LIBER ✦

High-dose interleukin-2 immunotherapy is safe for patients with metastatic renal cell carcinoma on dialysis

✍ Scribed by JOHN P. BRUSKY; FAWEZ GAILANI; APURBA PATHAK; HATEL PATEL; SHERIF ABOSEIF

Book ID: 109052235
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 59 KB
Volume: 97
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2006.05949.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The application of high-dose interleukin

The application of high-dose interleukin-2 for metastatic renal cell carcinoma

✍ David F. McDermott 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 192 KB

Prognostic markers for survival in patie

Prognostic markers for survival in patients with metastatic renal cell carcinoma treated with interleukin-2

✍ Rutger L. van Bezooijen; H. Goey; Gerrit Stoter; J. Hermans; G. J. Fleuren 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 473 KB

Long-term immunotherapy with low-dose in

Long-term immunotherapy with low-dose interleukin-2 and interferon-α in the treatment of patients with advanced renal cell carcinoma

✍ Carlo Buzio; Simeone Andrulli; Rosaria Santi; Laura Pavone; Rodolfo Passalacqua; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views

Treatment selection for patients with me

Treatment selection for patients with metastatic renal cell carcinoma: identification of features favoring upfront IL-2-based immunotherapy

✍ Michael B. Atkins 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 192 KB

Clinical outcome of combined immunothera

Clinical outcome of combined immunotherapy with low-dose interleukin-2 and interferon-α for Japanese patients with metastatic renal cell carcinoma who had undergone radical nephrectomy: a preliminary report

✍ Hideaki Miyake; Isao Hara; Iori Sakai; Ken-ichi Harada; Taka-aki Inoue; Hiroshi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 244 KB

Phase III, randomised, multicentre trial

Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-α for metastatic renal cell cancer

✍ Rodolfo Passalacqua; Carlo Buzio; Sebastiano Buti; Camillo Porta; Roberto Labian 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 284 KB